Myriad Genetics, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↓-31.2% -$321M
$707M
Current Assets↑+11.6% +$35M
$333M
Cash & Equivalents↑+46.1% +$47M
$150M
ST Investments
$0
Receivables↓-4.9% -$6M
$115M
Inventory↑+11.3% +$3M
$31M
Net PPE↓-2.9% -$3M
$114M
Goodwill↓-82.0% -$235M
$52M
Intangibles↓-41.5% -$109M
$153M
Total Liabilities↑+3.7% +$12M
$339M
Current Liabilities↓-18.5% -$30M
$134M
Account Payables↓-7.1% -$2M
$30M
Long-Term Debt↑+202.8% +$80M
$120M
Short-Term Debt
—
Stockholders Equity↓-47.5% -$333M
$368M
Retained Earnings↓-48.3% -$366M
$-1.12B
Operating Lease ROU Asset↓-10.2% -$6M
$49M
Operating Lease Liability↑+2.3% +$2M
$90M
Gross PP&E↓-11.1% -$25M
$202M
Accumulated Depreciation↓-19.8% -$22M
$88M
Total Debt Carrying Amount↑+208.6% +$85M
$125M
Contract Liability
—
Contract Liability (Current)
—
Remaining Performance Obligation
—
Pension Benefit Obligation
—
Pension Plan Assets
—